HIV

Men who have sex with men (MSM) can now participate in National Blood Donor Month under the FDA's updated guidelines, marking a crucial step toward addressing blood shortages and promoting inclusivity.

Interventions, such as asset-building, differential service delivery interventions, and digital interventions can help to improve health outcomes in adolescents with HIV.

Monitoring thyroid dysfunction from HIV could prevent hypothyroidism in the few patients who have these abnormalities.

People living with HIV in California were highly satisfied with telephone visits during the height of the COVID-19 pandemic and wanted to continue them in their regular care.

Lockdowns instituted due to the COVID-19 pandemic could have brought about exacerbated immune responses in people living with HIV.

Top articles about HIV this year included effects of HIV on tooth loss and cardiac surgery, caregiver experiences, and a federal ruling on military enlistment.

The prevalence of HPV81 in mother-child pairs with HIV in Nigeria could have implications on vaccination against human papillomavirus (HPV).

Stigma surrounding HIV can lead to barriers to health care, including refusal to get care, that could help individuals who are living with the condition.

Symptoms associated with long COVID were less frequent in patients living with HIV.

Tailored promotion of testing for HIV and sexually transmitted infections can help to reduce the incidence of HIV in adolescents.

Older adults with HIV provided insights into their preferences and experiences with virtual care to provide areas to target in practice and policy.

A qualitative study spoke to emergency department and HIV clinic staff to evaluate the feasibility of initiating pre-exposure prophylaxis (PrEP) in patients visiting the emergency department.

Women with higher symptoms of post-traumatic stress disorder and major depressive disorder after intimate partner violence were more likely to have higher motivation to receive pre-exposure prophylaxis (PrEP).

Women living with HIV can reduce their risk of cervical cancer using a human papillomavirus (HPV) vaccine that is both cost-effective and effective in preventing the virus.

An update from the PURPOSE 2 trial focused on adherence and pharmacokinetics data for lenacapavir, used to prevent HIV.

The combination therapy of bictegravir/emtricitabine/tenofovir (BIC/FTC/TAF) was both tolerable and produced virologic suppression in patients who were presenting late in their HIV infection.

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver conditions are prevalent for these individuals.

As part of our coverage of the biennial AIDS conference from the International AIDS Society, we spoke with Madalitso Juwayeyi, program manager at FACT-Malawi, to learn more about her organization and how it strives to serve the sexual and reproductive health needs of adolescent girls and young women in her native Malawi.

Specific subtypes and transmission clusters for HIV could require targeted interventions to control spread of HIV that is drug-resistant.

People living with HIV (PWH) can have mental health implications related to their neighborhood markers and environment.

Treatment effectiveness and safety can be affected by drug-related problems in patients who experience HIV treatment failure.

Patients living with HIV in Barcelona, Spain have seen a decrease in mortality of patients in critically ill condition admitted to the intensive care unit (ICU).

New data from the PURPOSE 2 trial continue to show the efficacy of lenacapavir in HIV prevention in individuals who have sex with men.

A phase 3b study found that Black individuals who switched to bictegravir/emtricitabine/tenofovir alafenamide were able to maintain virologic suppression after 72 weeks.

The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years.